Osher Van De Voorde Investment Management Johnson & Johnson Transaction History

Osher Van De Voorde Investment Management

$461 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 09, 2024	SELL	$145.6 - $158.88 $175,448 - $191,450	-1,205 Reduced 5.88%	19,293 $3.02 Million
Q3 2023 Oct 10, 2023	SELL	$155.75 - $174.48 $10.6 Million - $11.9 Million	-67,966 Reduced 76.83%	20,498 $3.19 Million
Q2 2023 Jul 24, 2023	SELL	$154.35 - $166.11 $13,119 - $14,119	-85 Reduced 0.1%	88,464 $14.6 Million
Q1 2023 Apr 11, 2023	SELL	$151.05 - $180.26 $118,574 - $141,504	-785 Reduced 0.88%	88,549 $13.7 Million
Q4 2022 Jan 12, 2023	SELL	$160.2 - $179.79 $96,120 - $107,874	-600 Reduced 0.67%	89,334 $0
Q3 2022 Oct 05, 2022	SELL	$161.33 - $179.52 $45,656 - $50,804	-283 Reduced 0.31%	89,934 $14.7 Million
Q2 2022 Jul 19, 2022	BUY	$168.19 - $186.01 $91,831 - $101,561	546 Added 0.61%	90,217 $16 Million
Q1 2022 Apr 14, 2022	BUY	$158.14 - $179.59 $581,164 - $659,993	3,675 Added 4.27%	89,671 $15.9 Million
Q4 2021 Jan 10, 2022	BUY	$155.93 - $173.01 $435,824 - $483,562	2,795 Added 3.36%	85,996 $14.7 Million
Q3 2021 Oct 19, 2021	BUY	$161.5 - $179.47 $379,040 - $421,216	2,347 Added 2.9%	83,201 $13.4 Million
Q2 2021 Jul 20, 2021	BUY	$159.48 - $171.07 $223,272 - $239,498	1,400 Added 1.76%	80,854 $13.3 Million
Q1 2021 Apr 13, 2021	BUY	$153.07 - $170.48 $148,477 - $165,365	970 Added 1.24%	79,454 $13.1 Million
Q4 2020 Jan 21, 2021	BUY	$137.11 - $157.38 $237,885 - $273,054	1,735 Added 2.26%	78,484 $12.4 Million
Q3 2020 Oct 13, 2020	BUY	$140.38 - $153.83 $229,521 - $251,512	1,635 Added 2.18%	76,749 $11.4 Million
Q2 2020 Jul 21, 2020	SELL	$128.81 - $155.51 $22,670 - $27,369	-176 Reduced 0.23%	75,114 $10.6 Million
Q1 2020 Apr 30, 2020	BUY	$111.14 - $153.99 $1.02 Million - $1.41 Million	9,137 Added 13.81%	75,290 $9.87 Million
Q4 2019 Feb 13, 2020	BUY	$127.5 - $146.44 $87,082 - $100,018	683 Added 1.04%	66,153 $9.65 Million
Q3 2019 Oct 15, 2019	BUY	$126.95 - $142.14 $75,916 - $84,999	598 Added 0.92%	65,470 $8.47 Million
Q2 2019 Aug 13, 2019	BUY	$131.15 - $144.24 $79,083 - $86,976	603 Added 0.94%	64,872 $9.04 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $2,262 - $2,516	-18 Reduced 0.03%	64,269 $8.98 Million
Q4 2018 Feb 15, 2019	BUY	$122.84 - $147.84 $17,688 - $21,288	144 Added 0.22%	64,287 $8.3 Million
Q3 2018 Nov 15, 2018	SELL	$121.58 - $142.88 $99,209 - $116,590	-816 Reduced 1.26%	64,143 $8.86 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $339,334 - $374,461	2,842 Added 4.58%	64,959 $7.88 Million
Q1 2018 May 11, 2018	BUY	$125.1 - $148.14 $5,629 - $6,666	45 Added 0.07%	62,117 $7.96 Million
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $155,622 - $162,726	-1,202 Reduced 1.9%	62,072 $8.07 Million
Q2 2017 Aug 15, 2017	BUY	N/A	63,274	63,274 $8.37 Million

Others Institutions Holding JNJ

# of Institutions

4,239

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Osher Van De Voorde Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Osher Van De Voorde Investment Management with notifications on news.

Account